Literature DB >> 1691195

Aberrant regulation of MyoD1 contributes to the partially defective myogenic phenotype of BC3H1 cells.

T J Brennan1, D G Edmondson, E N Olson.   

Abstract

Two skeletal muscle-specific regulatory factors, myogenin and MyoD1, share extensive homology within a myc similarity region and have each been shown to activate the morphologic and molecular events associated with myogenesis after transfection into nonmyogenic cells. The BC3H1 muscle cell line expresses myogenin and other muscle-specific genes, but does not express MyoD1 during differentiation. BC3H1 cells also do not upregulate alpha-cardiac actin or fast myosin light chain, nor do they form multinucleate myotubes during differentiation. In this study, we examined the basis for the lack of MyoD1 expression in BC3H1 cells and investigated whether their failure to express MyoD1 is responsible for their defects in differentiation. We report that expression of an exogenous MyoD1 cDNA in BC3H1 cells was sufficient to elevate the expression of alpha-cardiac actin and fast myosin light chain, and to convert these cells to a phenotype that forms multinucleate myotubes during differentiation. Whereas myogenin and MyoD1 positively regulated their own expression in transfected 10T1/2 cells, they could not, either alone or in combination, activate MyoD1 expression in BC3H1 cells. Exposure of BC3H1 cells to 5-azacytidine also failed to activate MyoD1 expression or to rescue the cell's ability to fuse. These results suggest that BC3H1 cells may possess a defect that prevents activation of the MyoD1 gene by MyoD1 or myogenin. That an exogenous MyoD1 gene could rescue those aspects of the differentiation program that are defective in BC3H1 cells also suggests that the actions of MyoD1 and myogenin are not entirely redundant and that MyoD1 may be required for activation of the complete repertoire of events associated with myogenesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1691195      PMCID: PMC2116110          DOI: 10.1083/jcb.110.4.929

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  41 in total

1.  A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program.

Authors:  D G Edmondson; E N Olson
Journal:  Genes Dev       Date:  1989-05       Impact factor: 11.361

2.  Sequential expression of smooth muscle and sarcomeric alpha-actin isoforms during BC3H1 cell differentiation.

Authors:  A R Strauch; J C Reeser
Journal:  J Biol Chem       Date:  1989-05-15       Impact factor: 5.157

3.  Regulation of differentiation of the BC3H1 muscle cell line through cAMP-dependent and -independent pathways.

Authors:  J S Hu; E N Olson
Journal:  J Biol Chem       Date:  1988-12-25       Impact factor: 5.157

4.  A muscle-specific enhancer is located at the 3' end of the myosin light-chain 1/3 gene locus.

Authors:  M Donoghue; H Ernst; B Wentworth; B Nadal-Ginard; N Rosenthal
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

5.  The oncogenic forms of N-ras or H-ras prevent skeletal myoblast differentiation.

Authors:  E N Olson; G Spizz; M A Tainsky
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

6.  Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent on protein synthesis and independent of cell proliferation.

Authors:  G Spizz; D Roman; A Strauss; E N Olson
Journal:  J Biol Chem       Date:  1986-07-15       Impact factor: 5.157

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  An activated c-Ha-ras allele blocks the induction of muscle-specific genes whose expression is contingent on mitogen withdrawal.

Authors:  P A Payne; E N Olson; P Hsiau; R Roberts; M B Perryman; M D Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

9.  Growth factors, signaling pathways, and the regulation of proliferation and differentiation in BC3H1 muscle cells. I. A pertussis toxin-sensitive pathway is involved.

Authors:  D J Kelvin; G Simard; H H Tai; T P Yamaguchi; J A Connolly
Journal:  J Cell Biol       Date:  1989-01       Impact factor: 10.539

10.  Epidermal growth factor controls smooth muscle alpha-isoactin expression in BC3H1 cells.

Authors:  Y C Wang; P A Rubenstein
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  35 in total

1.  Barx2 is expressed in satellite cells and is required for normal muscle growth and regeneration.

Authors:  Robyn Meech; Katie N Gonzalez; Marietta Barro; Anastasia Gromova; Lizhe Zhuang; Julie-Ann Hulin; Helen P Makarenkova
Journal:  Stem Cells       Date:  2012-02       Impact factor: 6.277

2.  MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells.

Authors:  Peter J Gianakopoulos; Virja Mehta; Anastassia Voronova; Yi Cao; Zizhen Yao; Josée Coutu; Xiaonan Wang; Michelle S Waddington; Stephen J Tapscott; Ilona S Skerjanc
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

3.  Wnt10b deficiency promotes coexpression of myogenic and adipogenic programs in myoblasts.

Authors:  Anthony M Vertino; Jane M Taylor-Jones; Kenneth A Longo; Edward D Bearden; Timothy F Lane; Robert E McGehee; Ormond A MacDougald; Charlotte A Peterson
Journal:  Mol Biol Cell       Date:  2005-01-26       Impact factor: 4.138

4.  Myogenic factors that regulate expression of muscle-specific microRNAs.

Authors:  Prakash K Rao; Roshan M Kumar; Mina Farkhondeh; Scott Baskerville; Harvey F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-26       Impact factor: 11.205

5.  Inefficient homooligomerization contributes to the dependence of myogenin on E2A products for efficient DNA binding.

Authors:  T Chakraborty; T J Brennan; L Li; D Edmondson; E N Olson
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

6.  Role of insulin-like growth factors and myogenin in the altered program of proliferation and differentiation in the NFB4 mutant muscle cell line.

Authors:  D D Sarbassov; R Stefanova; V G Grigoriev; C A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

7.  Regulation of the GLUT1 glucose transporter in cultured myocytes: total number and subcellular distribution as determined by photoaffinity labelling.

Authors:  I M el-Kebbi; S Roser; R J Pollet; S W Cushman; C M Wilson
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

8.  Further characterization of BC3H1 myogenic cells reveals lack of p53 activity and underexpression of several p53 regulated and extracellular matrix-associated gene products.

Authors:  Sandra B Sharp; Maria Villalvazo; Mickey Huang; Rodolfo Gonzalez; Irania Alarcon; Matthew Bahamonde; Diane M D'Agostin; Sagar Damle; Alex Espinosa; Seog J Han; Jessica Liu; Paula Navarro; Hugo Salguero; Jina Son; Son Vu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Jul-Aug       Impact factor: 2.416

9.  Bc3h1 myogenic cells produce an infectious ecotropic murine leukemia virus.

Authors:  Sandra B Sharp; Maria Villalvazo; Alex Espinosa; Sagar Damle; Xiomara Padilla; John Hartono; Rodolfo Gonzalez; Son Vu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002 Jul-Aug       Impact factor: 2.416

10.  Response of myogenic determination factors to cessation and resumption of electrical activity in skeletal muscle: a possible role for myogenin in denervation supersensitivity.

Authors:  C M Neville; M Schmidt; J Schmidt
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.